跳至主要内容
临床试验/NCT04780815
NCT04780815已完成不适用

An Exploratory PET-study of Deposition, Disposition and Brain Uptake of [11C]Nicotine After Inhalation of 2 Nicotine Formulations Via the myBluTM E-cigarette in Smokers

Imperial Brands PLC1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2020年3月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Lung PET

研究概览

简要总结

This is a single-center, exploratory positron emission tomography (PET) study of deposition, disposition and brain uptake [11C]nicotine when given to smokers as two different formulations via mybluTM e-cigarette system.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
50 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Body mass index ≥18.0 and ≤ 30.0 kg/m2
  • •Habitual daily cigarette smoker
  • •Women have to be of non-child bearing potential

排除标准

  • •History of any clinically significant disease
  • •Relevant concomitant medication
  • •Any clinically significant condition
  • •Malignancy within the past 5 years
  • •Positif for HIV, hepatitis B or C
  • •Untreated hypertension
  • •Previous participation to a PET-study or other nuclide medical study
  • •Previous exposure to significant radiation
  • •Negative results of the modified Allen test on both arms at screening
  • •Alcohol or drug abuse

研究组 & 干预措施

myBluTM Formulation 1 Oral cavity and lungs

Experimental

This group was used for measuring oral cavity and lungs endpoints after administration of Formulation 1

干预措施: myBluTM Formulation 1 (Other)

myBluTM Formulation 2 Oral cavity and lungs

Experimental

This group was used for measuring oral cavity and lungs endpoints after administration of Formulation 2

干预措施: myBluTM Formulation 2 (Other)

myBluTM Formulation 1 Brain

Experimental

This group was used for measuring brain endpoints after administration of Formulation 1

干预措施: myBluTM Formulation 1 (Other)

myBluTM Formulation 2 Brain

Experimental

This group was used for measuring brain endpoints after administration of Formulation 2

干预措施: myBluTM Formulation 2 (Other)

结局指标

主要结局

Lung PET

时间窗: 40 minutes

Peak accumulation of \[11C\]nicotine deposited in the lung during 40 minutes after product administration, using dynamic PET Digital Imaging and Communications in Medicine (DICOM) images over the lungs

Brain PET

时间窗: 30 minutes

Peak accumulation of nicotine deposited in the brain during 30 minutes after product administration, using dynamic PET Digital Imaging and Communications in Medicine (DICOM) images over the brain

Oral Cavity PET

时间窗: 40 minutes

Peak accumulation of nicotine deposited in the oral cavity during 40 minutes after product administration, using dynamic PET Digital Imaging and Communications in Medicine (DICOM) images over the oral cavity

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

An Exploratory PET-study of Deposition, Disposition... | 临床试验